Antibody screening approach could speed development of immune-based cancer treatments
A team led by Harvard Medical School researchers at Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute has developed a faster way to identify and engineer cancer-fighting therapies.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
AI could help predict which HPV infections progress to cancer
United Kingdom
-
Greater contact with nature linked to a more positive relationship with food
United Kingdom
-
Protein modification partially reverses cancer-related muscle wasting in preclinical study
United Kingdom
-
Engineers use AI, Reddit to identify potential side effects of unapproved new GLP-1
United Kingdom
-
Study finds prebiotic fiber helps girls build more bone
United Kingdom
-
Scientists restore memory-linked neuron function in Alzheimer's mice
United Kingdom
-
Who gets Alzheimer's drugs? Race, vulnerability and health status shape access
United Kingdom
-
Mount Sinai wins NIH grant to test community-based hypertension care model in rural Ghana
United Kingdom